India’s role as a global pharmacy will become more established as the country inoculates more than 100 cr COVID-19 vaccine, Health News, ET HealthWorld

New Delhi: When the country achieved the milestone of immunizing more than Rs 10 billion Indians against COVID-19 on Thursday, India’s role as a global pharmacy has been further established by countries that manufacture many drugs used to treat COVID vaccines and viruses.

Even after witnessing the turmoil caused by the two waves of the pandemic, India has emerged from its effects by strengthening its pharmaceutical sector and maintaining a resilient supply chain of essential medicines.

In an official statement, the center will strengthen vaccination momentum through more vaccine availability, a high degree of visibility into vaccine availability to states and coalition regions, and enable better planning with them. And to streamline the vaccine supply chain.

During the second wave of the pandemic around April this year, the Department of Pharmaceutical Sciences actively worked with manufacturers of these medicines to undertake the work of making essential COVID-related medicines available nationwide. rice field.

According to official information, drug production and availability monitoring is carried out by the Pharmaceutical Department (DoP), the National Drug Pricing Authority (NPPA) under the Pharmaceutical Department, and the Central Drugs Standard Control Organization (CDSCO), Health and Family Welfare. It is under the province (MoH & FW).

The COVID Drug Management Cell (CDMC) was officially established in the Pharmaceuticals Department (DoP) on April 26, this year to oversee the smooth supply of drugs used to manage COVID-19 during a pandemic. ..

During the pandemic, production of essential medicines such as remdesivir, liposomal amphotericin-B, especially the COVID-19 vaccine increased.

Licenses to manufacture remdesivir have been granted to seven Indian pharmaceutical companies. The domestic production capacity of all seven licensed manufacturers has been increased from 38 rack vials per month in April 2021 to approximately 122 rack vials per month in June 2021.

Liposomal amphotericin B, a drug used to treat mucor disease, also known as black fungus, was released between May and June 2021 by the Drugs Controller General of India (DCGI). A new license has been granted in favor of the manufacturer. To the 5 existing manufacturers of this drug. Domestic production also increased from 62,000 vials in April 2021 to 3.45 rack vials in July 2021. Similarly, imports increased significantly from 26,165 in April 2021 to 5.09 racks in July 2021.

It is interesting to see the country’s vaccination journey. India launched a national COVID vaccination drive on January 16, 2021. It began with vaccination of health care workers and then expanded to front-line workers, followed by people over the age of 60 and over 45 with comorbidity. After that, it was expanded to over 45 years old and further over 18 years old.

To strengthen the impetus for vaccination, pharmaceutical companies such as Bharat Biotech, Serum Institute of India, Zydus Cadila and Biological E have joined in to produce a sufficient number of vaccines.

When the world was on the verge of a pandemic, the country considered establishing a COVID-19 vaccine manufacturing unit to facilitate worldwide vaccine delivery. With the establishment of the vaccine manufacturing sector, countries around the world have considered supplying India.

Prior to the sixth edition of the Annual Program on the Pharmaceuticals and Medical Devices Sector (Indian Pharmaceuticals and Medical Devices 2021-) held in February this year, former Fertilizer Minister DV Sadananda Gouda said: A leading hub for affordable generics and medical devices and diagnostics. India supplies medicines to more than 200 countries and territories and will continue to fulfill its responsibilities. “

“The total market size of the Indian pharmaceutical industry is expected to reach US $ 130 billion by 2030. The Indian medical device industry could reach US $ 50 billion by 2025,” he said. Said.

Meanwhile, Minister of Health and Family Welfare Mansuf Mandaviya said, “During the pandemic, the Indian pharmaceutical industry provided the necessary medicines to more than 120 countries while meeting their needs. India is the world’s largest Covid-19. He said he has begun vaccination. It is a program and is the center of a global effort to provide vaccines to other countries. “

India, with its low-cost talent, urged the pharmaceutical sector to provide sufficient vaccines to other countries, while at the same time ensuring that its population was vaccinated.

During the COVID-19 pandemic, India’s position as a “pharmacy in the world” was not compromised.

Vaccine Mitri, an initiative initiated by the central government to deliver the COVID-19 vaccine to countries around the world, strengthens India’s credibility as a reliable and reliable manufacturer and supplier of high quality vaccines. Did.

On October 7, the government allowed the Indian Serum Research Institute (SII) to export 100,000 rupees of Kobishield to Nepal, Myanmar and Bangladesh, respectively. This allowed Bharat Biotech to provide Iran with a dose of Rs 100,000.

By exporting vaccines, India remains an important node in the global health supply chain and has established itself as a selfless contributor to global health and safety.

The country has emerged as a net provider of health security and has successfully taken on its responsibilities as a global pharmacy. During the pandemic, India continued to export important life-saving medicines to other countries.

Recently, national efforts have been noticed by foreign leaders. In March, Swedish Prime Minister Stefan Löfven appreciated India’s role as a global pharmacy.

Earlier, UN Secretary-General Antonio Guterres stated that India’s ability to produce vaccines is “one of the best assets the world has today.”

Calling India the “Pharmaceutical World”, in January the UK praised its efforts to produce coronavirus vaccines: “India already supplies more than 50% of the world’s vaccines, and the UK and India work closely together. I’ve been doing it. During the pandemic. “

In line with Neighborhood First policy, India has deployed Indian-made Covishield vaccines in several countries, including Bhutan, Myanmar, Bangladesh and Nepal, to support the fight against the COVID-19 pandemic. A dose of 100,000 rupees of covacin was exported to Iran under the vaccine mitri.

India’s role as a global pharmacy will become more established as the country inoculates more than 100 cr COVID-19 vaccine, Health News, ET HealthWorld

Source link India’s role as a global pharmacy will become more established as the country inoculates more than 100 cr COVID-19 vaccine, Health News, ET HealthWorld

Related Articles

Back to top button